PS 01. Testosterone replacement after prostate cancer treatment
Plenary Session

PS 01. Testosterone replacement after prostate cancer treatment

Arthur Burnett

Professor of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2101, USA

This presentation serves to present definitions of androgen deficiency, describe goals of therapy in the setting of patients having prostate cancer or treated for prostate cancer, and discuss the role, practical approach, and risk of testosterone replacement in the setting of prostate cancer.

DOI: 10.3978/j.issn.2223-4683.2012.s204

Article Options

Download Citation

Share